Arab World vs Latvia: Immunization, Hib3
Arab World
77.1%
in 2024
Latvia
97.0%
in 2024
Arab World rank
27th
Latvia rank
29th
Immunization, Hib3 over time
- Arab World
- Latvia
How they compare
Latvia currently reports 97.0% against 77.1% in Arab World, a difference of 19.9%.
That makes Latvia's figure about 1.3 times Arab World's.
Across all 31 years both countries report, Latvia has been ahead every year.
Arab World ranks 27th and Latvia ranks 29th of 43 groups.
Latvia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Arab World | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.4% | 48.8% | 48.5% | Latvia |
| 2000s | 23.0% | 92.1% | 69.1% | Latvia |
| 2010s | 73.4% | 94.2% | 20.8% | Latvia |
| 2020s | 80.9% | 96.4% | 15.5% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Arab World or Latvia?
- Latvia, at 97.0% against 77.1% in Arab World as of 2024.
- What is the difference in immunization, hib3 between Arab World and Latvia?
- 19.9%, with Latvia ahead.
- How many years of comparable data are there for Arab World and Latvia?
- 31 years are reported by both, from 1994 to 2024.
- How do Arab World and Latvia rank globally for immunization, hib3?
- Arab World ranks 27th and Latvia ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.